bioAffinity CyPath Lung Test Improves Cancer Diagnosis
SAN ANTONIO, TX, March 17, 2026 bioAffinity Technologies, Inc. has released a new clinical case study demonstrating how its...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
SAN ANTONIO, TX, March 17, 2026 bioAffinity Technologies, Inc. has released a new clinical case study demonstrating how its...
IRVING, Texas, February 26, 2026 Caris Life Sciences® (NASDAQ: CAI) announced an interim readout from its Achieve 1 clinical...
New York, USA & Tel Aviv, Israel — February 26, 2026 NeuraLight has announced the presentation of next-generation brain-function...
PARMA, ITALY — February 17, 2026 Copan Diagnostics announced that its AI-enabled microbiology imaging system PhenoMATRIX has received U.S....
Seoul, South Korea — February 6, 2026 Neurophet has announced that the U.S. Food and Drug Administration (FDA) has...
mlHealth 360 has received U.S. FDA 510(k) clearance for Scaida BrainCT-ICH, the first Canada-developed AI-powered triage solution designed to...
RICHMOND, VA – October 17, 2025: BrainBox Solutions has published a major analysis in JAMA Network OPEN from its...
BASEL, Switzerland, Oct. 6, 2025 — Roche announced that it has received CE-mark approval for the AI-based Kidney Klinrisk...
